Mr. Chris Shields reports

RELIQ HEALTH TECHNOLOGIES, INC. PROVIDES UPDATE ON STATUS OF MANAGEMENT CEASE TRADE ORDER

Reliq Health Technologies Inc. has provided this update on the status of a management cease trade order granted on Oct. 31, 2023, by the British Columbia Securities Commission under National Policy 12-203, Management Cease Trade Orders. On Oct. 31, 2023, the company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management discussion and analysis for the fiscal year ended June 30, 2023, beyond the period prescribed under applicable Canadian securities laws. Subsequently, there has been a delay in the filing of the company's interim financial statements for the period ended Sept. 30, 2023, that were due for filing on Nov. 29, 2023.

As indicated in its news releases dated Dec. 11, 2023, and Dec. 15, 2023, the company has recently gone through changes to its management team during its audit. Given these recent changes of management, coupled with the limited availability of staff during the holidays, the company applied for and received an extension of its MCTO by the BCSC. The company is now required to complete its annual filings by Jan. 12, 2024, with the interim filings being due for filing within five business days after the annual filings have been filed.

"We would like to thank our shareholders for their continued patience as we work with our auditors towards the finish line," said Chris Shields, interim chief executive officer of the company. "The company will continue to provide updates on the progress of its audit through regular news releases."

During the MCTO, the general investing public will continue to be able to trade in the company's listed common shares. However, the company's chief executive officer and chief financial officer will not be able to trade in the company's shares.

Other than as disclosed in this news release, there are no material changes to the information contained in the default announcement. The company confirms that it intends to satisfy the provisions of NP 12-203 and will continue to issue biweekly default status reports for so long as it remains in default of the annual filings and interim filings requirement. The company expects to file its annual filings on or before Jan. 12, 2024, and expects to file its interim filings within five business days after the annual filings are completed. Further updates on timing will be provided by the company as necessary.

About Reliq Health Technologies Inc.

Reliq Health Technologies is a rapidly growing global health care technology company that specializes in developing innovative virtual care solutions for the multibillion-dollar health care market. Reliq's powerful iUGO Care platform supports care co-ordination and community-based virtual health care. iUGO Care allows complex patients to receive high-quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER (emergency room) visits. Reliq Health Technologies trades on the TSX Venture Exchange under the symbol RHT, on the OTC (over-the-counter) market as RQHTF and on the Frankfurt Stock Exchange under WKN: A2AJTB.

We seek Safe Harbor.